2YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
Canagliflozin | 卡格列净 | 842133-18-0 |
CaproMorelin Tartrate | 卡普瑞林酒石酸盐 | 193273-69-7 |
Ulixertinib | 4-[5-氯-2-[(1-甲基乙基)氨基]-4-吡啶基]-N-[(1S)-1-(3-氯苯基)-2-羟基乙基]-1H-吡咯-2-甲酰胺 | 869886-67-9 |
Fostemsavir Tris | FOSTEMSAVIR TROMETHAMINE | 864953-39-9 |
Nalfurafine N-Oxide | Nalfurafine N-Oxide | 208042-42-6 |
LSY-05 | Lys05 | 1391426-24-6 |
BMS-986205 | BMS-986205 | 1923833-60-6 |
Gusacitinib | GUSACITINIB | 1425381-60-7 |
CD-38 | CD38 inhibitor | 1700637-55-3 |
10,12-HEPTACOSADIYNOIC ACID | 10,12-十七二炔酸 | 67071-94-7 |
Benzaldehyde, 4,4',4''-[phosphinylidynetris(oxy)]tris- | 159213-46-4 | |
2-Propenamide, N-(cyanomethyl)- | 2-丙烯酰胺,N-(氰基甲基)- | 64186-79-4 |
Theliatinib tartrate | XILIERTINIB TARTRATE|||HMPL-309 TARTRATE|||XILIERTINIB TARTRATE ; HMPL-309 TARTRATE | 2413487-72-4 |
2-(oxolan-2-yl)acetic acid | (四氢呋喃-2-基)乙酸 | 2434-00-6 |
befiradol | 贝非拉醇 | 208110-64-9 |
Omarigliptin (MK-3102) | 奥格列汀(MK-3102) | 1226781-44-7 |
Temsavir | 1-(4-苯甲酰基哌嗪-1-基)-2-[4-甲氧基-7-(3-甲基-1H-1, 2, 4-三氮唑-1-基)-1H-吡咯并[2,3-C]吡啶-3-基)乙烷-1,2-二酮 | 701213-36-7 |
GSK 2330672 | GSK 2330672 | 1345982-69-5 |
1,2,4,5-benzene tetracarboxalaldehyde | 1,2,4,5-苯四醛 | 14674-89-6 |
Senexin B | 4-[[2-[6-[(4-甲基-1-哌嗪基)羰基]-2-萘基]乙基]氨基]-6-喹唑啉甲腈 | 1449228-40-3 |
3,4-Diaminofurazan | 3,4-二氨基呋扎 | 17220-38-1 |
1,1'-Bis[3-(trimethylammonio)propyl]-4,4'-bipyridinium Tetrachloride Dihydrate | 1,1'-双[3-(三甲基铵)丙基]-4,4'-联吡啶四氯化物 二水合物 | 108228-37-1 |
DTRIM24 | dTRIM24 | 2170695-14-2 |
HS-10296 | 阿美替尼 | 1899921-05-1 |
Amphiregulin | AMPHIREGULIN HUMAN RECOMBINANT | 117147-70-3 |
MRTX849 analog 24 | 4-[7-(8-CHLORO-1-NAPHTHALENYL)-5,6,7,8-TETRAHYDRO-2-[[(2S)-1-(4-PENTYN-1-YL)-2- | 2490716-96-4 |
3,7-Dibenzothiophenedicarboxaldehyde, 5,5-dioxide | 二苯并[B,D]噻吩-3,7-二甲醛5,5-二氧化物 | 82487-47-6 |
JAB-3068 hydrochloride | 2169223-49-6 | |
ADG 126 | 抗 Human CD152/CTLA4 (ADG 126) 单克隆抗体 | |
YF135 | 2913177-53-2 | |
N-Phenyl-N'-(2-methylphenyl)-p-phenylenediamine | N1-苯基-N4-(邻甲苯基)苯-1,4-二胺 | 27173-16-6 |
1-Pentanone, 4-methyl-1-phenyl-2-(1-pyrrolidinyl)-, hydrochloride (1:1) | N-[4-[[(3-甲氧基吡嗪基)氨基]磺酰基]苯基]-3-(5-硝基-2-噻吩基)-2-丙烯酰胺 | 432531-71-0 |
DescyclopropylMethyl Nalfurafine | DescyclopropylMethyl Nalfurafine | 163713-06-2 |
CTP-354 | CTP354 | 1213669-91-0 |
Theliatinib | 席栗替尼 | 1353644-70-8 |
BMS-813160 | CS-2742 | 1286279-29-5 |
R-(+)-ETOMOXIR | 乙莫克舍 | 124083-20-1 |
BPK29 | BPK-29 | 2143467-62-1 |
Deruxtecan | 德鲁替康 | 1599440-13-7 |
Nirogacestat dihydrobromide | PF 3084014 HYDROBROMIDE | 1962925-29-6 |
NaV1.7 inhibitor-1 | NaV1.7 inhibitor-1 | 1494585-79-3 |
N-(4-bromophenyl)-N-di(4-pyridyl)amine | N-(4-溴苯基)-N-(吡啶-4-基)吡啶-4-胺 | 1218812-58-8 |
Doramapimod | 1-[2-(4-甲基苯基)-5-叔丁基吡唑-3-基]-3-[4-(2-吗啉-4-基乙氧基)萘-1-基]脲 | 285983-48-4 |
Elranatamab | 埃纳妥单抗 | 2408850-14-4 |
Lumacaftor | 鲁玛卡托 | 936727-05-8 |
TPPB | TPPB | 497259-23-1 |
Fostemsavir | 福斯特沙韦 | 864953-29-7 |
1-((tert-butoxycarbonyl)(Methyl)aMino)cyclopropanecarboxylic acid | 1-((叔丁氧羰基)(甲基)氨基)环丙烷-1-羧酸 | 119145-87-8 |
AZD8186 | 8-[(1R)-1-[(3,5-二氟苯基)氨基]乙基]-N,N-二甲基-2-(4-吗啉基)-4-氧代-4H-1-苯并吡喃-6-甲酰胺 | 1627494-13-6 |
NMDI14 | NMDI14 | 307519-88-6 |
BMS-986142 | BMS986142 | 1643368-58-4 |
(S)-Ceralasertib | (S)-CERALASERTIB | 1352226-87-9 |
IA-14069 | 2271216-04-5 | |
2H-1-Benzopyran-4-carboxamide, 7-bromo-3,4-dihydro-, (4R)- | 1851374-84-9 | |
Zearalenone | 玉米烯酮 | 17924-92-4 |
Nirogacestat | PF-3084014 | 1290543-63-3 |
Rimegepant | 瑞美吉泮 | 1289023-67-1 |
CPI-360 | EZH2抑制剂(CPI-360) | 1802175-06-9 |
Hyodeoxycholic acid | 猪去氧胆酸 | 83-49-8 |
Gusacitinib hydrochloride | ASN-002_Hydrochloride | 2228989-14-6 |
BMS-P5 | BMS-P5 | 1550371-22-6 |
SM-102 | SM-102 | 2089251-47-6 |
NA | [3,3':4',3"- 三(1,2,5- 恶二唑)]-4,4"-二胺 | 7741-27-6 |
LX-4211 | 索格列净 | 1018899-04-1 |
A-385358 | A-385358 | 406228-55-5 |
Ulixertinib hydrochloride | BVD-523 盐酸盐 | 1956366-10-1 |
SB-431542 | SB-431542 | 301836-41-9 |
Irinotecan Impurity 18 | 伊立替康杂质18 | 1255644-71-3 |
5-Tetracenecarboxylic Acid | 并四苯-5-羧酸 | 858455-70-6 |
BHS697 | BHS697 | 943189-02-4 |
2,3,5,6-Pyrazinetetracarboxylic acid | 49193-60-8 | |
(3R,5R,6S)-Atogepant ((3R,5R,6S)-MK-8031) | ||
Bictegravir | 比克替拉韦 | 1611493-60-7 |
pyrazino[2,3-g]quinoxaline | pyrazino[2,3-g]quinoxaline | 261-43-8 |
Benzenamine, 2-(2-propenyl)- | 2-烯丙基苯胺 | 32704-22-6 |
ASTX-029 | ASTX-029 | 2095719-92-7 |
SB 215505 | 6-氯-2,3-二氢-5-甲基-N-5-喹啉基-1H-吲哚-1-甲酰胺 | 162100-15-4 |
ALC-0159 | 甲氧基聚乙二醇双十四烷基乙酰胺 | 1849616-42-7 |
3-Perylenecarboxaldehyde | 3-苝甲醛 | 35438-63-2 |
Sulfatinib | 5-羟基-2-甲基吲哚 | 1308672-74-3 |
(E)-N-[(4R,4aS,7S,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-yl]-3-(furan-3-yl)-N-methylprop-2-enamide | (E)-N-[(4R,4aS,7S,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-yl]-3-(furan-3-yl)-N-methylprop-2-enamide | 152658-36-1 |
dBRD9 | DBRD9 | 2170679-45-3 |
1,4-Benzenedicarboxylic acid, 2,3-difluoro- | 2,3-二氟对苯二甲酸 | 1220509-29-4 |
Navitoclax-piperazine | ABT-263-piperazine | 2143096-93-7 |
JAB-3068 | JAB-3068 | 2169223-48-5 |
LC-2 | PROTAC KRASG12C Degrader-LC-2 | 2502156-03-6 |
ALC-0315 | ALC-0315 | 2036272-55-4 |
1,2,5-Oxadiazol-3-amine, 4,4'-(1,2,4-oxadiazole-3,5-diyl)bis- (9CI) | 1 | 405278-80-0 |
MRTX849 ethoxypropanoic acid | 3-[3-[(2S)-2-[[[7-(8-CHLORO-1-NAPHTHALENYL)-4-[(3S)-3-(CYANOMETHYL)-4-(2-FLUORO- | 2561529-98-2 |
MRTX849 acid | MRTX849-溴丙酸衍生物 | 2561529-96-0 |
(R)-(+)-Etomoxir sodium salt | (R)-(+)-乙莫克舍钠盐 | 828934-41-4 |
Belotecan | CKD-602 盐酸盐 | 213819-48-8 |
GSK215 | GSK215 | 2743427-26-9 |
2-(Diphenylphosphino)terephthalic acid | 2-(二苯基膦基)对苯二甲酸 | 1537175-69-1 |
MK-8031 | 阿托吉泮 | 1374248-81-3 |
5-Chloro-8-methyl-7-(3-methylbut-2-en-1-yl)-6,7,8,9-tetrahydro-2,7,9a-triazabenzo[cd]azulene-1(2H)-thione | 5-氯-8-甲基-7-(3-甲基丁-2-烯-1-基)-6,7,8,9-四氢-2,7,9a-三氮杂苯并[cd]薁-1(2H)-硫酮 | 257891-65-9 |
Desmorpholinyl Navitoclax-NH-Me | 化合物DESMORPHOLINYL NAVITOCLAX-NH-ME | 2365172-82-1 |
N,N'-bis(2-methylphenyl)benzene-1,4-diamine | N,N'-双(2-甲基苯基)苯-1,4-二胺 | 15017-02-4 |
Befiradol hydrochloride | SYNONYMS: NLX-112 HYDROCHLORIDE; F 13640 HYDROCHLORIDE | 2436760-81-3 |
Talquetamab | 塔奎妥单抗 | 2226212-40-2 |
联系方式